Bjork Elisabeth 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-13+23,944→ 23,944 totalExercise: $22.86Exp: 2034-06-13→ Common Stock (23,944 underlying) - Award
Stock Option (Right to Buy)
2024-06-13$15.04/sh+3,325$50,008→ 3,325 totalExercise: $22.86Exp: 2034-06-13→ Common Stock (3,325 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025.
- [F2]This option represents a right to purchase a total of 3,325 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.